Literature DB >> 713589

Lymph node mapping and curability at various levels of metastasis in resected lung cancer.

T Naruke, K Suemasu, S Ishikawa.   

Abstract

By means of lymph mapping, the prognosis significance of lymph node metastasis in lung cancer was studied in 270 patients who had undergone radical operations--pulmonary resection combined with complete mediastinal lymph node disection, which is used for patients in whom all cancer could thereby be ablated. Mediastinal lymph node metastasis was found in 64 patients, and 12 patients lived 5 years or more (an absolute 5 year survival rate of 18.8 percent). After radical surgery, there was a significant difference between the prognosis for patients who had metastases to the subcrainal lymph nodes as compared to the prognosis for those who did not. The 5 years survival rates were 9.1 percent and 29.0 percent, respectively. On the other hand, prognosis was not significantly affected by involvement or noninvolvement of the superior mediastinal, paratracheal, tracheobronchial, pretracheal, and the subaortic and para-aortic lymph nodes. No significant difference in survival was detected between patients who were given adjuvant therapy and those who were not. Lymph node mapping gives valuable prognostic information.

Entities:  

Mesh:

Year:  1978        PMID: 713589

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  89 in total

Review 1.  Last-intercalated node and direct lymphatic drainage into the thoracic duct from the thoracoabdominal viscera.

Authors:  Gen Murakami; Masato Abe; Tomio Abe
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-03

Review 2.  [Endobronchial ultrasound in bronchial carcinoma].

Authors:  F J F Herth; H D Becker; R Eberhardt
Journal:  Radiologe       Date:  2004-05       Impact factor: 0.635

3.  Remembrance: Keiichi Suemasu, MD, 1926-2015.

Authors:  Hisao Asamura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-11

4.  Intraoperative sentinel lymph node mapping of the lung using near-infrared fluorescent quantum dots.

Authors:  Edward G Soltesz; Sungjee Kim; Rita G Laurence; Alec M DeGrand; Cherie P Parungo; Delphine M Dor; Lawrence H Cohn; Moungi G Bawendi; John V Frangioni; Tomislav Mihaljevic
Journal:  Ann Thorac Surg       Date:  2005-01       Impact factor: 4.330

5.  Expression of the chemokine receptor CCR6 correlates with a favorable prognosis in patients with adenocarcinoma of the lung.

Authors:  Yoshihiro Minamiya; Hajime Saito; Naoko Takahashi; Manabu Ito; Hiroshi Toda; Takashi Ono; Hayato Konno; Satoru Motoyama; Jun-Ichi Ogawa
Journal:  Tumour Biol       Date:  2010-09-25

6.  Early recurrence of completely resected N2-positive non-small-cell lung cancer.

Authors:  Takuma Tsukioka; Noritoshi Nishiyama; Takashi Iwata; Nobuhiro Izumi; Shinjiro Mizuguchi; Ryuhei Morita; Kiyotoshi Inoue; Shigefumi Suehiro
Journal:  Gen Thorac Cardiovasc Surg       Date:  2007-03

7.  Predicting the prognosis of lung cancer: the evolution of tumor, node and metastasis in the molecular age-challenges and opportunities.

Authors:  Ramón Rami-Porta; Hisao Asamura; Peter Goldstraw
Journal:  Transl Lung Cancer Res       Date:  2015-08

8.  Impact of main bronchial lymph node involvement in pathological T1-2N1M0 non-small-cell lung cancer: multi-institutional survey by the Japan National Hospital Study Group for Lung Cancer.

Authors:  Hajime Maeda; Shimao Fukai; Akihide Matsumura; Osamu Kawashima; Takehiro Watanabe; Takeshi Yamanda; Kan Okabayashi; Yuka Fujita; Atsuhisa Tamura; Masaaki Kawahara
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-11-12

9.  Transbronchial needle aspiration in clinical practice.

Authors:  E M Harrow; F A Oldenburg; A M Smith
Journal:  Thorax       Date:  1985-10       Impact factor: 9.139

10.  Pulmonary angioplastic procedure for lung cancer surgery.

Authors:  Motohiro Yamashita; Eisaku Komori; Shigeki Sawada; Hiroshi Suehisa; Isao Nozaki; Akira Kurita; Shigemitsu Takashima
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.